Dendritic cell-based vaccination of patients with advanced pancreatic carcinoma: results of a pilot study
✍ Scribed by Christian Bauer; Marc Dauer; Samira Saraj; Maximilian Schnurr; Franz Bauernfeind; Alexander Sterzik; Jana Junkmann; Veronika Jakl; Rosemarie Kiefl; Fuat Oduncu; Bertold Emmerich; Doris Mayr; Thomas Mussack; Christiane Bruns; Dominik Rüttinger; Claudius Conrad; Karl-Walter Jauch; Stefan Endres; Andreas Eigler
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 388 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In a pilot phase 1/11 study we have tested synthetic ras peptides used as a cancer vaccine in 5 patients with advanced pancreatic carcinoma. The treatment principle used was based on loading professional antigen-presenting cells (APCs) from peripheral blood with a synthetic ras peptide corresponding